Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Transgene

Clinical trials sponsored by Transgene, explained in plain language.

Transgene TNG EURONEXT PARIS

A biotech company developing viral vector-based immunotherapies for cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 2 Completed 1 Terminated 1

Cancer-Fighting virus injected directly into tumors shows promise in early trial

Disease control Terminated

This early-phase trial tested a new treatment called BT-001, a virus designed to infect and kill cancer cells, given alone or with the immunotherapy drug pembrolizumab. The study involved 31 people with advanced solid tumors like melanoma, lung cancer, or sarcoma that had spread.…

Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC